Related Experiment Video
Updated: Apr 24, 2026

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
The placebo effect on psychomotor performance and working memory capacity: randomized single blind cross-over trial
1Department of Pharmacology, College of Medicine, Al-Mustansiriya University, PO Box 14132, Baghdad, IRAQ.
Background:
Imaging studies show that placebo enhance release of dopamine in the mesolimbic and mesocortical tracts. Dopamine in these areas are involved in attention and working memory function.
Purpose:
We wanted to investigating the effect of placebo on psychomotor function and working memory capacity.
Method:
31 medical students participated in this single blind, crossover trial. Choice reaction time, critical flicker fusion threshold, n-back working memory tasks measured before and after one hour of the students receiving placebo in three different occasions as stimulant, unknown, and inert substance.
Results:
Placebo, as stimulant, significantly enhanced choice reaction time and working memory function (P < 0.05) while showed no significant effect on critical flicker fusion threshold (P > 0.05). Placebo as unknown significantly deteriorates working memory capacity (P < 0.05). Placebo as inert substance shows no significant changes regarding choice reaction time, critical flicker fusion threshold, and working memory task.
Conclusion:
Placebo, as stimulant enhanced attention and improved working memory capacity, while as unknown may deteriorate working memory function.
More Related Videos
08:50How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
The Placebo Effect
Blind Procedures
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Working Memory